Abberant methylation of the Wnt antagonist SFRP1 in breast cancer

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:153 / 154
页数:2
相关论文
共 50 条
  • [31] WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth
    Matsuda, Yutaka
    Schlange, Thomas
    Oakeley, Edward J.
    Boulay, Anne
    Hynes, Nancy E.
    BREAST CANCER RESEARCH, 2009, 11 (03):
  • [32] WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth
    Yutaka Matsuda
    Thomas Schlange
    Edward J Oakeley
    Anne Boulay
    Nancy E Hynes
    Breast Cancer Research, 11
  • [33] Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients
    Rawson, James B.
    Manno, Michael
    Mrkonjic, Miralem
    Daftary, Darshana
    Dicks, Elizabeth
    Buchanan, Daniel D.
    Younghusband, H. Banfield
    Parfrey, Patrick S.
    Young, Joanne P.
    Pollett, Aaron
    Green, Roger C.
    Gallinger, Steven
    McLaughlin, John R.
    Knight, Julia A.
    Bapat, Bharati
    CARCINOGENESIS, 2011, 32 (05) : 741 - 747
  • [34] SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway
    Chung, Ming-Tzeung
    Lai, Hung-Cheng
    Sytwu, Huey-Kang
    Yan, Ming-De
    Shih, Yu-Lueng
    Chang, Cheng-Chang
    Yu, Mu-Hsien
    Liu, Hang-Seng
    Chu, Da-Wei
    Lin, Ya-Wen
    GYNECOLOGIC ONCOLOGY, 2009, 112 (03) : 646 - 653
  • [36] Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer does not rely on WNT signaling
    Christof Bernemann
    Carolin Hülsewig
    Christian Ruckert
    Sarah Schäfer
    Lena Blümel
    Georg Hempel
    Martin Götte
    Burkhard Greve
    Peter J Barth
    Ludwig Kiesel
    Cornelia Liedtke
    Molecular Cancer, 13
  • [37] Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer does not rely on WNT signaling
    Bernemann, Christof
    Huelsewig, Carolin
    Ruckert, Christian
    Schaefer, Sarah
    Bluemel, Lena
    Hempel, Georg
    Goette, Martin
    Greve, Burkhard
    Barth, Peter J.
    Kiesel, Ludwig
    Liedtke, Cornelia
    MOLECULAR CANCER, 2014, 13
  • [38] Methylation-associated silencing of SFRP1 in renal cell carcinoma
    Awakura, Yasuo
    Nakamura, Eijiro
    Ito, Noriyuki
    Kamoto, Toshiyuki
    Ogawa, Osamu
    ONCOLOGY REPORTS, 2008, 20 (05) : 1257 - 1263
  • [39] Transcriptional down-regulation of the Wnt antagonist SFRP1 in haematopoietic cells of patients with different risk types of MDS
    Reins, Jana
    Mossner, Maximilian
    Neumann, Martin
    Platzbecker, Uwe
    Schumann, Christiane
    Thiel, Eckhard
    Hofmann, Wolf-Karsten
    LEUKEMIA RESEARCH, 2010, 34 (12) : 1610 - 1616
  • [40] SFRP1 promoter methylation and expression in human trabecular meshwork cells
    Mao, Weiming
    Rubin, Jeffrey S.
    Anoruo, Nancy
    Wordinger, Robert J.
    Clark, Abbot F.
    EXPERIMENTAL EYE RESEARCH, 2012, 97 (01) : 130 - 136